PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Conference Call 3/8/21, page-50

  1. 3,837 Posts.
    lightbulb Created with Sketch. 652
    I think you summed it up brilliantly, you love those long flights, and I hate them.

    biotechs for me are a bit like flying from Perth to New York, with all the expected stopovers…but then they throw in heaps of unexpected delays at each stop along the way!

    I think I love the arrival routine at the first airport the best, where I feel full of optimism and excitement and thoughts of “I've made it to the airport on time and they have checked me in. What could possibly go wrong?”

    For me, PAR was fabulous up until the confirmation of all the secondary endpoints for the phase 2 trial…then two years of setting up this phase 3 trial for the go ahead has been a real mood killer! I didn’t expect the time between finishing the awesome phase 2 study and the permission to start a phase 3 study would have taken so long.

    ii guess I should shut up, or I will make you miserable, too!

    I really admire your staying power!


    Last edited by hotcongo: 05/08/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.